176 related articles for article (PubMed ID: 28601720)
1. Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.
Zhang X; Guo S; Chen C; Perez GR; Zhang C; Patanapongpibul M; Subrahmanyam N; Wang R; Keith J; Chen G; Dong Y; Zhang Q; Zhong Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2017 Sep; 137():263-279. PubMed ID: 28601720
[TBL] [Abstract][Full Text] [Related]
2. Optimization of diarylpentadienones as chemotherapeutics for prostate cancer.
Patanapongpibul M; Zhang C; Chen G; Guo S; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2018 Sep; 26(16):4751-4760. PubMed ID: 30121214
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models.
Wang R; Zhang X; Chen C; Chen G; Sarabia C; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2017 Jun; 133():208-226. PubMed ID: 28388523
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
[TBL] [Abstract][Full Text] [Related]
5. Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.
Wang R; Chen C; Zhang X; Zhang C; Zhong Q; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
J Med Chem; 2015 Jun; 58(11):4713-26. PubMed ID: 25961334
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
Li X; Zhang C; Guo S; Rajaram P; Lee M; Chen G; Fong R; Gonzalez A; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2018 Sep; 157():978-993. PubMed ID: 30165345
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.
Zhang X; Wang R; Perez GR; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2016 Oct; 24(19):4692-4700. PubMed ID: 27543391
[TBL] [Abstract][Full Text] [Related]
8. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.
Vue B; Zhang S; Zhang X; Parisis K; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Feb; 109():36-46. PubMed ID: 26748997
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents.
Mochona B; Qi X; Euynni S; Sikazwi D; Mateeva N; Soliman KF
Bioorg Med Chem Lett; 2016 Jun; 26(12):2847-2851. PubMed ID: 27156770
[TBL] [Abstract][Full Text] [Related]
10. 3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.
Li X; Lee M; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4768-4777. PubMed ID: 28760528
[TBL] [Abstract][Full Text] [Related]
11. 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells.
Zhang S; Vue B; Huang M; Zhang X; Lee T; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem Lett; 2016 Jul; 26(14):3226-3231. PubMed ID: 27261177
[TBL] [Abstract][Full Text] [Related]
12. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
13.
Chowrasia D; Jafri A; Azad I; Rais J; Sharma N; Khan F; Kumar A; Kumar S; Arshad M
J Biomol Struct Dyn; 2022 Nov; 40(18):8569-8586. PubMed ID: 33955334
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective synthesis and anti-proliferative effects on prostate cancer evaluation of 5-substituted-3,4-diphenylfuran-2-ones.
Liu GZ; Xu HW; Wang P; Lin ZT; Duan YC; Zheng JX; Liu HM
Eur J Med Chem; 2013 Jul; 65():323-36. PubMed ID: 23735281
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
Ramya PVS; Guntuku L; Angapelly S; Digwal CS; Lakshmi UJ; Sigalapalli DK; Babu BN; Naidu VGM; Kamal A
Eur J Med Chem; 2018 Jan; 143():216-231. PubMed ID: 29174816
[TBL] [Abstract][Full Text] [Related]
16. Substituted dienes prepared from betulinic acid - Synthesis, cytotoxicity, mechanism of action, and pharmacological parameters.
Pokorný J; Olejníková D; Frydrych I; Lišková B; Gurská S; Benická S; Šarek J; Kotulová J; Hajdúch M; Džubák P; Urban M
Eur J Med Chem; 2021 Nov; 224():113706. PubMed ID: 34311159
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of chalcone-polyamine conjugates as novel vectorized agents in colorectal and prostate cancer chemotherapy.
Rioux B; Pinon A; Gamond A; Martin F; Laurent A; Champavier Y; Barette C; Liagre B; Fagnère C; Sol V; Pouget C
Eur J Med Chem; 2021 Oct; 222():113586. PubMed ID: 34116328
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 1,4-pentadien-3-one derivatives containing quinoxaline scaffolds as potential apoptosis inducers.
Tang X; He J; Li Q; Tang X; Chen M; Hao G; Huai Z; Huang Y; Xue W
Future Med Chem; 2020 Aug; 12(16):1505-1519. PubMed ID: 32772720
[No Abstract] [Full Text] [Related]
20. Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies.
Fawzy NG; Panda SS; Fayad W; El-Manawaty MA; Srour AM; Girgis AS
Anticancer Agents Med Chem; 2019; 19(8):1069-1078. PubMed ID: 30961509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
